Press Releases is unique and effective promotional tool offered from Worldpharmatoday.com aimed at bringing our client’s business message into limelight and more importantly make it reach their target audience. This feature can be utilized to launch new product, promoting existing Pharma product, publish business agreements, annual reports, financial results, corporate performances, important announcements or any important information that has to be conveyed to the target audience.
To add free press releases please click here.
Patheon has added a new filling technology that significantly reduces the time needed for formulation development and stability testing at its facility in Milton Park, UK.
The Xcelodose 600 S Automated Encapsulator supports early phase development for oral dose products.
An expert from Patheon will highlight the company's strategy for delivering exceptional customer experience through its integrated offerings at the Seventh Annual Global Biomanufacturing Summit.
Lonza has announced an agreement for the supply of TiGenix's eASC product, Cx601.Under the agreement, Lonza will manufacture material for the Phase III trial of Cx601 in the US at Lonza's cell therapy production facility in Walkersville, Maryland.
TxCell, a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, today reports its revenues as of December 31, 2014 and updates on forthcoming milestones.
Dr. Parvinder Punia, Senior regulatory expert will present “European experience of harmonising the pharmaceutical market” at Moscow conference on February 10th 2015
Cambridge, UK, 2nd February 2015 – ELC Group, one of the fastest-growing providers of regulatory affairs, today announces that its Senior Regulatory Affairs Manager Dr Parvinder Punia will be an invited speaker at the 3rd Annual Regulatory & Legal Affairs in Russia conference being held at the Marriott Grand Hotel in Moscow from February 10th – 12th 2015.
80% of the finalists for the ‘Most Valuable Patient Initiative’ Categoryof the 2015 eyeforpharma Philadelphia Awards are focussing on education as a means of engaging with andimproving the lives of patients.
eyeforpharma, London (January, 19, 2015): According to LEO Pharma, Ipsen and Grünenthaldriving patient-centric leadership has become priority as the patient voice shapes the future for the pharmaceutical industry.
Page 1 of 67